Background: The prevalence of hepatotoxicity after longterm oral amiodarone therapy in
Chinese patients with or without elevated liver enzymes at baseline is unknown. Hypothesis …

Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

Objectives Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …

Background: Amiodarone is associated with varying degrees of hepatotoxicity. Aims: to
study the association between the presence of the metabolic syndrome or rightsided heart …

Background Amiodarone is a highly effective treatment for supraventricular and ventricular
tachyarrhythmia; however, it could be associated with several serious adverse effects …

This cross-sectional, retrospective study was designed to evaluate the current clinical
applications and acute hepatotoxicity of intravenous amiodarone administration at a hospital …

After many years of benign use in Europe, amiodarone developed a reputation for frequent
adverse effects after its introduction to North America at higher doses. 1, 2 Two decades …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Background Liver cirrhosis is an uncommon but not rare side effect of amiodarone-induced
hepatotoxicity. Patients with hepatitis B virus and hepatitis C virus infections are at a high …

Abstract Background/Aim The number of patients receiving amiodarone will increase in
future years. As clinically significant hepatotoxicity associated with oral amiodarone is …